Hereditary Angioedema Market Research Report 2019-2025

Hereditary Angioedema Market

Hereditary angioedema is a rare disease and is mostly mistaken for common allergic reactions and abdominal pain. This mainly on account of the lack of knowledge among both physicians and patients about the condition. About 40% of the affected patients are diagnosed correctly with hereditary angioedema in the US and Europe. With progress in diagnostic field and different initiatives undertaken by patient bodies and industry players to spread awareness, the market for hereditary angioedema is projected to grow.

In 2019, the market size of Hereditary Angioedema is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.

In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Hereditary Angioedema.

Download FREE Sample of this Report @

This report studies the global market size of Hereditary Angioedema, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).

This study presents the Hereditary Angioedema sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:

  • Pharming Group NV
  • Shire plc
  • CSL Limited
  • iBio Inc.
  • BioCryst Pharmaceuticals, Inc.
  • Ionis Pharmaceuticals, Inc.

Market Segment by Product Type

  • C1 Esterase Inhibitor
  • Kallikrein Inhibitor
  • Selective Bradykinin B2 Receptor Antagonist

Market Segment by Application

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

Key Regions split in this report: breakdown data for each region.

  • United States
  • China
  • European Union
  • Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:

  • To analyze and research the Hereditary Angioedema status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
  • To present the key Hereditary Angioedema manufacturers, presenting the sales, revenue, market share, and recent development for key players.
  • To split the breakdown data by regions, type, companies and applications
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends, drivers, influence factors in global and regions
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Hereditary Angioedema are as follows:

  • History Year: 2014–2018
  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Year 2019 to 2025

Get the Complete Report & TOC @

Table of content

1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Hereditary Angioedema Market Size Growth Rate by Type (2019–2025)
1.3.2 C1 Esterase Inhibitor
1.3.3 Kallikrein Inhibitor
1.3.4 Selective Bradykinin B2 Receptor Antagonist
1.4 Market Segment by Application

2 Global Growth Trends
2.1 Global Hereditary Angioedema Market Size
2.1.1 Global Hereditary Angioedema Revenue 2014–2025
2.1.2 Global Hereditary Angioedema Sales 2014–2025
2.2 Hereditary Angioedema Growth Rate by Regions
2.2.1 Global Hereditary Angioedema Sales by Regions 2014–2019
2.2.2 Global Hereditary Angioedema Revenue by Regions 2014–2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Hereditary Angioedema Sales by Manufacturers
3.1.1 Hereditary Angioedema Sales by Manufacturers 2014–2019
3.1.2 Hereditary Angioedema Sales Market Share by Manufacturers 2014–2019

276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170 / +91 8087042414

Follow Us On linkedin :-


Please enter your comment!
Please enter your name here